Shukra Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	121.18	99.8	39.73	2.9	5.04
Cash & Short-Term Investments	133.58	121.18	99.8	39.73	2.9	5.04
Cash Growth	-25.93%	21.41%	151.21%	1271.89%	-42.59%	299.07%
Accounts Receivable	-	87.67	245.13	301.87	74.01	97.48
Other Receivables	-	193.25	64.67	82.3	-	-
Receivables	-	383.22	329.59	406.95	99.5	132.1
Inventory	-	99.53	23.14	31.57	39.54	16.82
Prepaid Expenses	-	0.11	0.17	0.22	0.59	0.31
Other Current Assets	-	50.24	109.62	52.25	16.2	6.33
Total Current Assets	-	654.27	562.33	530.72	158.72	160.6
Property, Plant & Equipment	-	213.43	216.05	218.95	192.41	193.53
Long-Term Investments	-	-	-	-	-	1.95
Total Assets	-	867.7	778.37	749.66	351.13	356.08
Accounts Payable	-	92.16	72.21	336.22	85.9	53.29
Accrued Expenses	-	15.37	10.81	9.18	10.33	7.83
Current Portion of Long-Term Debt	-	10.64	4.97	13.13	2.5	-
Current Unearned Revenue	-	26.44	35.28	66.12	24.68	8.45
Other Current Liabilities	-	28.22	18.25	0.42	0.36	0.78
Total Current Liabilities	-	172.84	141.53	425.06	123.77	70.35
Long-Term Debt	-	31.13	26.57	37.68	31.27	97.71
Pension & Post-Retirement Benefits	-	1.27	1.15	1.08	-	-
Long-Term Deferred Tax Liabilities	-	34.11	32.73	32.87	32.6	32.03
Other Long-Term Liabilities	-	-	-	-0	-0	-
Total Liabilities	-	239.34	201.98	496.7	187.63	200.09
Common Stock	-	437.88	109.47	39.14	15.66	15.66
Additional Paid-In Capital	-	47.4	91.19	22.79	-	-
Retained Earnings	-	143	375.66	191.13	147.84	140.34
Comprehensive Income & Other	-	0.08	0.08	-0.09	-	-
Shareholders' Equity	658.06	628.36	576.4	252.97	163.5	155.99
Total Liabilities & Equity	-	867.7	778.37	749.66	351.13	356.08
Total Debt	37.56	41.77	31.54	50.82	33.77	97.71
Net Cash (Debt)	96.02	79.41	68.27	-11.09	-30.87	-92.66
Net Cash Growth	-37.28%	16.33%	-	-	-	-
Net Cash Per Share	0.13	0.18	0.16	-0.16	-0.49	-1.48
Filing Date Shares Outstanding	433.29	437.88	438.39	438.39	62.63	62.63
Total Common Shares Outstanding	433.29	437.88	438.39	438.39	62.63	62.63
Working Capital	-	481.44	420.79	105.66	34.95	90.25
Book Value Per Share	1.38	1.44	1.31	0.58	2.61	2.49
Tangible Book Value	658.06	628.36	576.4	252.97	163.5	155.99
Tangible Book Value Per Share	1.38	1.44	1.31	0.58	2.61	2.49
Land	-	1.72	1.72	1.72	1.7	1.72
Buildings	-	125.26	125.26	116.73	100.5	100.4
Machinery	-	307.27	282.68	277.22	248.6	233.14
Construction In Progress	-	19.45	16.62	16.62	16.62	16.62

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.